Illumina starts job cuts, plans office exit to rein in costs

ILLUMINA has commenced job cuts, the genetic sequencing equipment maker said on Monday (Jun 26), as it looks to cushion the impact of sticky inflation and a strong dollar on its business.

The company also intends to further cut the workforce in the third quarter and reducing its real estate footprint in California as part of a plan to reduce annualised run rate expenses by more than US$100 million in 2023.

Illumina has begun to lay off 10 per cent of its research and development team, health news website Stat reported on Monday, citing internal emails.

However, the company did not confirm the number of employees it laid off.

Illumina, which had engaged in a proxy battle with activist investor Carl Icahn, earlier this month said CEO Francis deSouza had stepped down.

The reduction in workforce commenced on Jun 21 and will result in charges of about US$25 to US$35 million, the company said, with the majority incurred in the second quarter.

SEE ALSO

Illumina’s US$7b Grail deal vetoed by European Union

DECODING ASIA

Navigate Asia in
a new global order

Get the insights delivered to your inbox.

Illumina’s core global workforce comprised about 10,200 full-time employees as of Jan 1, according to a regulatory filing. REUTERS